PCVX insider filings
Vaxcyte, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-13. Screen PCVX transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 17 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 17 legs across 8 filings by 3 insiders — 67,692 shares, $5,185,988 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 31.
- Largest priced transaction: sale of 19,000 shares @ $86.74 ($1,648,060) by Cowan Elvia, filed 2026-10-07.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Wassil Jim — EVP, Chief Scientific Ofc, COO | 5 | — | 11 legs · 28,692 sh · $2,202,072 | 11 |
| Cowan Elvia — SVP, Finance & CAO | 4 | — | 3 legs · 22,000 sh · $1,830,813 | 7 |
| Dhaliwal Harpreet S. — Chief Technical Ops Officer | 3 | — | 3 legs · 17,000 sh · $1,153,103 | 5 |
| GUGGENHIME ANDREW — PRESIDENT AND CFO | 2 | — | — | 3 |
| PICKERING GRANT — CHIEF EXECUTIVE OFFICER, Director | 2 | — | — | 3 |
| Jodar Luis — Chief Medical Officer | 1 | — | — | 2 |
Recent insider filings — Vaxcyte, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | Dhaliwal Harpreet S. — Chief Technical Ops Officer | Option exercise (M): 17,000 @ $24.79 · Sale (S): 7,135 @ $67.33 · Sale (S): 9,345 @ $68.16 · Sale (S): 520 @ $68.82 · Option exercise (M): 17,000 (derivative) @ $0 | EDGAR |
| 2026-11-04 | 4 | Wassil Jim — EVP, Chief Scientific Ofc, COO | Option exercise (M): 2,250 @ $5.35 · Sale (S): 1,907 @ $60.78 · Sale (S): 343 @ $61.57 · Option exercise (M): 2,250 (derivative) @ $0 | EDGAR |
| 2026-11-04 | 4 | Cowan Elvia — SVP, Finance & CAO | Option exercise (M): 3,000 @ $25.92 · Sale (S): 2,414 @ $60.77 · Sale (S): 586 @ $61.55 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2026-10-07 | 4 | Cowan Elvia — SVP, Finance & CAO | Option exercise (M): 19,000 @ $25.92 · Sale (S): 19,000 @ $86.74 · Option exercise (M): 19,000 (derivative) @ $0 | EDGAR |
| 2026-10-07 | 4 | Wassil Jim — EVP, Chief Scientific Ofc, COO | Option exercise (M): 18,000 @ $5.35 · Sale (S): 18,000 @ $86.74 · Option exercise (M): 18,000 (derivative) @ $0 | EDGAR |
| 2026-10-02 | 4 | Wassil Jim — EVP, Chief Scientific Ofc, COO | Option exercise (M): 2,250 @ $5.35 · Sale (S): 2,155 @ $56.65 · Sale (S): 95 @ $57.09 · Option exercise (M): 2,250 (derivative) @ $0 | EDGAR |
| 2026-09-09 | 4 | GUGGENHIME ANDREW — PRESIDENT AND CFO | Tax withholding (F): 7,155 @ $60.36 | EDGAR |
| 2026-09-09 | 4 | PICKERING GRANT — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 17,056 @ $60.36 | EDGAR |
| 2026-09-09 | 4 | Cowan Elvia — SVP, Finance & CAO | Tax withholding (F): 1,327 @ $60.36 | EDGAR |
| 2026-09-09 | 4 | Dhaliwal Harpreet S. — Chief Technical Ops Officer | Tax withholding (F): 7,651 @ $60.36 | EDGAR |
| 2026-09-09 | 4 | Wassil Jim — EVP, Chief Scientific Ofc, COO | Sale (S): 1,381 @ $61.16 · Tax withholding (F): 5,459 @ $60.36 · Sale (S): 1,334 @ $59.52 | EDGAR |
| 2026-09-09 | 4 | Jodar Luis — Chief Medical Officer | Grant/award (A): 52,632 @ $0 · Grant/award (A): 88,254 (derivative) @ $0 | EDGAR |
| 2026-09-02 | 4 | PICKERING GRANT — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 2,862 @ $60.74 · Tax withholding (F): 3,427 @ $61.58 | EDGAR |
| 2026-09-02 | 4 | Wassil Jim — CHIEF OPERATING OFFICER | Tax withholding (F): 1,273 @ $60.74 · Option exercise (M): 2,250 @ $5.35 · Sale (S): 1,537 @ $60.89 · Sale (S): 713 @ $61.48 · Sale (S): 924 @ $60.95 · Sale (S): 303 @ $61.42 · +2 more | EDGAR |
| 2026-09-02 | 4 | Cowan Elvia — SVP, Finance & CAO | Tax withholding (F): 243 @ $60.74 · Tax withholding (F): 326 @ $61.58 | EDGAR |
| 2026-09-02 | 4 | Dhaliwal Harpreet S. — Chief Technical Ops Officer | Tax withholding (F): 361 @ $60.74 · Tax withholding (F): 659 @ $61.58 | EDGAR |
| 2026-09-02 | 4 | GUGGENHIME ANDREW — PRESIDENT AND CFO | Tax withholding (F): 1,273 @ $60.74 · Tax withholding (F): 1,432 @ $61.58 | EDGAR |
| 2026-08-05 | 4 | Dhaliwal Harpreet S. — Chief Technical Ops Officer | Option exercise (M): 17,000 @ $24.79 · Sale (S): 17,000 @ $55.00 · Option exercise (M): 17,000 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | GUGGENHIME ANDREW — PRESIDENT AND CFO | Option exercise (M): 10,000 @ $5.35 · Sale (S): 6,956 @ $53.76 · Sale (S): 3,044 @ $54.18 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Wassil Jim — CHIEF OPERATING OFFICER | Option exercise (M): 2,250 @ $5.35 · Sale (S): 861 @ $53.50 · Sale (S): 1,389 @ $54.09 · Option exercise (M): 2,250 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | PICKERING GRANT — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 16,198 @ $2.03 · Sale (S): 11,783 @ $55.52 · Sale (S): 4,415 @ $55.93 · Sale (S): 756 @ $55.52 · Sale (S): 244 @ $55.96 · Sale (S): 622 @ $55.54 · +2 more | EDGAR |
| 2026-07-16 | 4 | Markels John — Director | Grant/award (A): 23,029 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Wassil Jim — CHIEF OPERATING OFFICER | Option exercise (M): 516 @ $5.35 · Sale (S): 1,788 @ $56.03 · Sale (S): 456 @ $57.47 · Sale (S): 6 @ $57.82 · Option exercise (M): 516 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | GUGGENHIME ANDREW — PRESIDENT AND CFO | Option exercise (M): 10,000 @ $5.35 · Sale (S): 7,913 @ $57.16 · Sale (S): 2,087 @ $57.76 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | PICKERING GRANT — CHIEF EXECUTIVE OFFICER, Director | Sale (S): 6,683 @ $54.27 · Sale (S): 9,137 @ $55.27 · Sale (S): 6,417 @ $56.12 · Sale (S): 312 @ $54.34 · Sale (S): 356 @ $55.23 · Sale (S): 332 @ $55.99 · +3 more | EDGAR |
| 2026-06-23 | 4 | Slaoui Moncef — Director | Grant/award (A): 26,061 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | PICKERING GRANT — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 225 @ $1.79 · Sale (S): 225 @ $52.51 · Sale (S): 22,236 @ $52.50 · Sale (S): 1,000 @ $52.50 · Sale (S): 1,000 @ $52.50 · Option exercise (M): 225 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | GUGGENHIME ANDREW — PRESIDENT AND CFO | Option exercise (M): 10,000 @ $5.35 · Sale (S): 10,000 @ $53 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Lee Jacks — Director | Grant/award (A): 2,265 @ $0 · Grant/award (A): 11,389 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Loxam Teri — Director | Grant/award (A): 2,265 @ $0 · Grant/award (A): 11,389 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Furey John — Director | Grant/award (A): 2,265 @ $0 · Grant/award (A): 11,389 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Paya Carlos V — Director | Grant/award (A): 2,265 @ $0 · Grant/award (A): 11,389 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Gilbert Halley E — Director | Grant/award (A): 2,265 @ $0 · Grant/award (A): 11,389 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Lukatch Heath — Director | Grant/award (A): 2,265 @ $0 · Grant/award (A): 11,389 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | BRANDICOURT OLIVIER — Director | Grant/award (A): 2,194 @ $0 · Grant/award (A): 11,034 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Drapeau Anne S — Director | Grant/award (A): 2,265 @ $0 · Grant/award (A): 11,389 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Wassil Jim — CHIEF OPERATING OFFICER | Sale (S): 1,949 @ $49.40 · Sale (S): 301 @ $50.26 | EDGAR |
| 2026-05-01 | 4 | Wassil Jim — CHIEF OPERATING OFFICER | Sale (S): 2,250 @ $56.83 | EDGAR |
| 2026-04-08 | 4 | Cowan Elvia — SVP, Finance & CAO | Option exercise (M): 3,000 @ $25.92 · Sale (S): 3,000 @ $60 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Wassil Jim — CHIEF OPERATING OFFICER | Sale (S): 1,412 @ $58.14 · Sale (S): 838 @ $58.93 | EDGAR |
| 2026-03-18 | 4 | Cowan Elvia — SVP, Finance & CAO | Sale (S): 1,487 @ $55.39 · Sale (S): 405 @ $56.26 | EDGAR |
| 2026-03-11 | 4 | Cowan Elvia — SVP, Finance & CAO | Tax withholding (F): 495 @ $59.32 · Option exercise (M): 2,500 @ $25.92 · Sale (S): 2,500 @ $58.59 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Dhaliwal Harpreet S. — Chief Technical Ops Officer | Tax withholding (F): 604 @ $59.32 | EDGAR |
| 2026-03-11 | 4 | Wassil Jim — CHIEF OPERATING OFFICER | Tax withholding (F): 975 @ $59.32 · Sale (S): 2,427 @ $58.32 · Sale (S): 4,968 @ $59.16 | EDGAR |
| 2026-03-11 | 4 | PICKERING GRANT — CHIEF EXECUTIVE OFFICER, Director | Tax withholding (F): 3,685 @ $59.32 | EDGAR |
| 2026-03-11 | 4 | GUGGENHIME ANDREW — PRESIDENT AND CFO | Tax withholding (F): 1,021 @ $59.32 | EDGAR |
| 2026-03-02 | 4 | Dhaliwal Harpreet S. — Chief Technical Ops Officer | Grant/award (A): 53,409 @ $0 · Tax withholding (F): 292 @ $61.98 · Tax withholding (F): 465 @ $61.98 · Grant/award (A): 46,424 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Wassil Jim — CHIEF OPERATING OFFICER | Grant/award (A): 32,045 @ $0 · Grant/award (A): 5,102 @ $61.74 · Tax withholding (F): 1,900 @ $61.74 · Tax withholding (F): 898 @ $61.98 · Tax withholding (F): 1,009 @ $61.98 · Grant/award (A): 53,566 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | PICKERING GRANT — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 105,110 @ $0 · Tax withholding (F): 2,863 @ $61.98 · Tax withholding (F): 2,531 @ $61.98 · Grant/award (A): 175,698 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | GUGGENHIME ANDREW — PRESIDENT AND CFO | Grant/award (A): 44,864 @ $0 · Tax withholding (F): 898 @ $61.98 · Tax withholding (F): 1,009 @ $61.98 · Grant/award (A): 74,993 (derivative) @ $0 | EDGAR |
Recent 8-K events — Vaxcyte, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-05 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PCVX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs